Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver disease: a nationwide case-control study in South Korea

{ 'indexed': {'date-parts': [[2024, 8, 28]], 'date-time': '2024-08-28T00:27:28Z', 'timestamp': 1724804848886}, 'reference-count': 54, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2024, 8, 27]], 'date-time': '2024-08-27T00:00:00Z', 'timestamp': 1724716800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}, { 'start': { 'date-parts': [[2024, 8, 27]], 'date-time': '2024-08-27T00:00:00Z', 'timestamp': 1724716800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}], 'funder': [{'name': 'Dong-A University Research Fund'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1186/s12985-024-02464-1', 'type': 'journal-article', 'created': {'date-parts': [[2024, 8, 27]], 'date-time': '2024-08-27T18:03:13Z', 'timestamp': 1724781793000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver ' 'disease: a nationwide case-control study in South Korea', 'prefix': '10.1186', 'volume': '21', 'author': [ {'given': 'Sang Yi', 'family': 'Moon', 'sequence': 'first', 'affiliation': []}, {'given': 'Minkook', 'family': 'Son', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yeo Wool', 'family': 'Kang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Myeongseok', 'family': 'Koh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jong Yoon', 'family': 'Lee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yang Hyun', 'family': 'Baek', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 8, 27]]}, 'reference': [ { 'key': '2464_CR1', 'doi-asserted-by': 'publisher', 'first-page': '1015', 'DOI': '10.1016/S0140-6736(20)30673-5', 'volume': '395', 'author': 'J Bedford', 'year': '2020', 'unstructured': 'Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, ' 'Lane HC, Memish Z, Oh MD, Sall AA, et al. COVID-19: towards controlling ' 'of a pandemic. Lancet. 2020;395:1015–8.', 'journal-title': 'Lancet'}, { 'key': '2464_CR2', 'doi-asserted-by': 'publisher', 'first-page': '1009393', 'DOI': '10.3389/fpubh.2022.1009393', 'volume': '10', 'author': 'S Naseer', 'year': '2022', 'unstructured': 'Naseer S, Khalid S, Parveen S, Abbass K, Song H, Achim MV. COVID-19 ' 'outbreak: impact on global economy. Front Public Health. ' '2022;10:1009393.', 'journal-title': 'Front Public Health'}, { 'key': '2464_CR3', 'doi-asserted-by': 'publisher', 'first-page': '855', 'DOI': '10.1186/s12879-021-06536-3', 'volume': '21', 'author': 'ZG Dessie', 'year': '2021', 'unstructured': 'Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a ' 'systematic review and meta-analysis of 42 studies and 423,117 patients. ' 'BMC Infect Dis. 2021;21:855.', 'journal-title': 'BMC Infect Dis'}, { 'key': '2464_CR4', 'doi-asserted-by': 'publisher', 'first-page': 'e0254258', 'DOI': '10.1371/journal.pone.0254258', 'volume': '16', 'author': 'YJ Choi', 'year': '2021', 'unstructured': 'Choi YJ, Park JY, Lee HS, Suh J, Song JY, Byun MK, Cho JH, Kim HJ, Park ' 'HJ. Variable effects of underlying diseases on the prognosis of patients ' 'with COVID-19. PLoS ONE. 2021;16:e0254258.', 'journal-title': 'PLoS ONE'}, { 'key': '2464_CR5', 'doi-asserted-by': 'publisher', 'first-page': '12', 'DOI': '10.5009/gnl220327', 'volume': '17', 'author': 'L Baldelli', 'year': '2023', 'unstructured': 'Baldelli L, Marjot T, Barnes E, Barritt AS, Webb GJ, Moon AM. SARS-CoV-2 ' 'infection and liver disease: a review of Pathogenesis and outcomes. Gut ' 'Liver. 2023;17:12–23.', 'journal-title': 'Gut Liver'}, { 'key': '2464_CR6', 'doi-asserted-by': 'publisher', 'first-page': '322', 'DOI': '10.1002/hep.31649', 'volume': '74', 'author': 'GN Ioannou', 'year': '2021', 'unstructured': 'Ioannou GN, Liang PS, Locke E, Green P, Berry K, O’Hare AM, Shah JA, ' 'Crothers K, Eastment MC, Fan VS, Dominitz JA. Cirrhosis and severe Acute ' 'Respiratory Syndrome Coronavirus 2 infection in US veterans: risk of ' 'infection, hospitalization, Ventilation, and Mortality. Hepatology. ' '2021;74:322–35.', 'journal-title': 'Hepatology'}, { 'key': '2464_CR7', 'doi-asserted-by': 'publisher', 'first-page': '1988', 'DOI': '10.1111/liv.14984', 'volume': '41', 'author': 'CW Spearman', 'year': '2021', 'unstructured': 'Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: a ' '2021 update. Liver Int. 2021;41:1988–98.', 'journal-title': 'Liver Int'}, { 'key': '2464_CR8', 'doi-asserted-by': 'publisher', 'first-page': '348', 'DOI': '10.1038/s41575-021-00426-4', 'volume': '18', 'author': 'T Marjot', 'year': '2021', 'unstructured': 'Marjot T, Webb GJ, Barritt ASt, Moon AM, Stamataki Z, Wong VW, Barnes E. ' 'COVID-19 and liver disease: mechanistic and clinical perspectives. Nat ' 'Rev Gastroenterol Hepatol. 2021;18:348–64.', 'journal-title': 'Nat Rev Gastroenterol Hepatol'}, { 'key': '2464_CR9', 'doi-asserted-by': 'publisher', 'first-page': '1487', 'DOI': '10.1053/j.gastro.2021.07.010', 'volume': '161', 'author': 'J Ge', 'year': '2021', 'unstructured': 'Ge J, Pletcher MJ, Lai JC. Outcomes of SARS-CoV-2 infection in patients ' 'with chronic liver disease and cirrhosis: a National COVID Cohort ' 'Collaborative Study. Gastroenterology. 2021;161:1487–e15011485.', 'journal-title': 'Gastroenterology'}, { 'key': '2464_CR10', 'doi-asserted-by': 'publisher', 'first-page': '889', 'DOI': '10.1002/hep4.1853', 'volume': '6', 'author': 'AM Moon', 'year': '2022', 'unstructured': 'Moon AM, Webb GJ, García-Juárez I, Kulkarni AV, Adali G, Wong DK, Lusina ' 'B, Dalekos GN, Masson S, Shore BM, et al. SARS-CoV-2 infections among ' 'patients with Liver Disease and Liver Transplantation who received ' 'COVID-19 vaccination. Hepatol Commun. 2022;6:889–97.', 'journal-title': 'Hepatol Commun'}, { 'key': '2464_CR11', 'doi-asserted-by': 'publisher', 'first-page': '1633', 'DOI': '10.1038/s41467-023-37176-7', 'volume': '14', 'author': 'D Cromer', 'year': '2023', 'unstructured': 'Cromer D, Steain M, Reynaldi A, Schlub TE, Khan SR, Sasson SC, Kent SJ, ' 'Khoury DS, Davenport MP. Predicting vaccine effectiveness against severe ' 'COVID-19 over time and against variants: a meta-analysis. Nat Commun. ' '2023;14:1633.', 'journal-title': 'Nat Commun'}, { 'key': '2464_CR12', 'doi-asserted-by': 'publisher', 'first-page': '881', 'DOI': '10.1007/s12072-020-10077-3', 'volume': '14', 'author': 'R Zampino', 'year': '2020', 'unstructured': 'Zampino R, Mele F, Florio LL, Bertolino L, Andini R, Galdo M, De Rosa R, ' 'Corcione A, Durante-Mangoni E. Liver injury in remdesivir-treated ' 'COVID-19 patients. Hepatol Int. 2020;14:881–3.', 'journal-title': 'Hepatol Int'}, { 'key': '2464_CR13', 'doi-asserted-by': 'publisher', 'first-page': '151', 'DOI': '10.1053/j.gastro.2022.09.008', 'volume': '164', 'author': 'GL Wong', 'year': '2023', 'unstructured': 'Wong GL, Hui VW, Yip TC, Lui GC, Hui DS, Wong VW. Minimal risk of ' 'Drug-Induced Liver Injury with Molnupiravir and Ritonavir-Boosted ' 'Nirmatrelvir. Gastroenterology. 2023;164:151–3.', 'journal-title': 'Gastroenterology'}, { 'key': '2464_CR14', 'doi-asserted-by': 'publisher', 'first-page': '668', 'DOI': '10.1038/s41591-021-01310-z', 'volume': '27', 'author': 'L Gaziano', 'year': '2021', 'unstructured': 'Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson ' 'SA, Ho Y-L, Iyengar SK, Kosik NM, Vujkovic M, et al. Actionable ' 'druggable genome-wide mendelian randomization identifies repurposing ' 'opportunities for COVID-19. Nat Med. 2021;27:668–76.', 'journal-title': 'Nat Med'}, { 'key': '2464_CR15', 'doi-asserted-by': 'publisher', 'first-page': '134', 'DOI': '10.1038/s41586-022-05594-0', 'volume': '615', 'author': 'T Brevini', 'year': '2023', 'unstructured': 'Brevini T, Maes M, Webb GJ, John BV, Fuchs CD, Buescher G, Wang L, ' 'Griffiths C, Brown ML, Scott WE, et al. FXR inhibition may protect from ' 'SARS-CoV-2 infection by reducing ACE2. Nature. 2023;615:134–42.', 'journal-title': 'Nature'}, { 'key': '2464_CR16', 'doi-asserted-by': 'publisher', 'first-page': '1178590', 'DOI': '10.3389/fcimb.2023.1178590', 'volume': '13', 'author': 'Y Li', 'year': '2023', 'unstructured': 'Li Y, Zhu N, Cui X, Lin Y, Li X. Protective effect of ursodeoxycholic ' 'acid on COVID-19 in patients with chronic liver disease. Front Cell ' 'Infect Microbiol. 2023;13:1178590.', 'journal-title': 'Front Cell Infect Microbiol'}, { 'key': '2464_CR17', 'doi-asserted-by': 'publisher', 'first-page': '636', 'DOI': '10.1111/joim.13630', 'volume': '293', 'author': 'BV John', 'year': '2023', 'unstructured': 'John BV, Bastaich D, Webb G, Brevini T, Moon A, Ferreira RD, Chin AM, ' 'Kaplan DE, Taddei TH, Serper M, et al. Ursodeoxycholic acid is ' 'associated with a reduction in SARS-CoV-2 infection and reduced severity ' 'of COVID-19 in patients with cirrhosis. J Intern Med. 2023;293:636–47.', 'journal-title': 'J Intern Med'}, { 'key': '2464_CR18', 'doi-asserted-by': 'crossref', 'unstructured': 'Hu L, Zhang H, Huang C, Shen T, Feng Z, Mu F, Xu L, Lin Y, Yue C, Guo K, ' 'et al. Effect of Ursodeoxycholic Acid on preventing SARS-CoV-2 infection ' 'in patients with liver transplantation: a multicenter retrospective ' 'cohort study. Qjm; 2023.', 'DOI': '10.1093/qjmed/hcad254'}, { 'key': '2464_CR19', 'doi-asserted-by': 'crossref', 'unstructured': 'Colapietro F, Angelotti G, Masetti C, Shiffer D, Pugliese N, De Nicola ' 'S, Carella F, Desai A, Ormas M, Calatroni M et al. Ursodeoxycholic Acid ' 'Does Not Improve COVID-19 Outcome in Hospitalized Patients. Viruses : ' '2023, 15.', 'DOI': '10.3390/v15081738'}, { 'key': '2464_CR20', 'doi-asserted-by': 'publisher', 'first-page': '1950', 'DOI': '10.1111/liv.15660', 'volume': '43', 'author': 'T Liu', 'year': '2023', 'unstructured': 'Liu T, Wang JS. Ursodeoxycholic acid administration did not reduce ' 'susceptibility to SARS-CoV-2 infection in children. Liver Int. ' '2023;43:1950–4.', 'journal-title': 'Liver Int'}, { 'key': '2464_CR21', 'doi-asserted-by': 'publisher', 'first-page': '83', 'DOI': '10.1111/liv.15736', 'volume': '44', 'author': 'G Marrone', 'year': '2024', 'unstructured': 'Marrone G, Covino M, Merra G, Piccioni A, Amodeo A, Novelli A, Murri R, ' 'Pompili M, Gasbarrini A, Franceschi F. Ursodeoxycholic acid does not ' 'affect the clinical outcome of SARS-CoV-2 infection: a retrospective ' 'study of propensity score-matched cohorts. Liver Int. 2024;44:83–92.', 'journal-title': 'Liver Int'}, { 'key': '2464_CR22', 'doi-asserted-by': 'publisher', 'first-page': 'e29418', 'DOI': '10.1002/jmv.29418', 'volume': '96', 'author': 'C Corpechot', 'year': '2024', 'unstructured': 'Corpechot C, Verdoux M, Frank-Soltysiak M, Duclos-Vallée JC, Grimaldi L. ' 'Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a ' 'real-word setting. J Med Virol. 2024;96:e29418.', 'journal-title': 'J Med Virol'}, { 'key': '2464_CR23', 'unstructured': 'Nation Health Insurance Data Sharing Service. 2024. ' '[https://nhiss.nhis.or.kr/bd/ab/bdaba000eng.do]'}, { 'key': '2464_CR24', 'unstructured': 'ATC/DDD, Index. 2024. ' '[https://atcddd.fhi.no/atc_ddd_index/code=A05AA02]'}, { 'key': '2464_CR25', 'doi-asserted-by': 'publisher', 'first-page': '676', 'DOI': '10.1093/aje/kwq433', 'volume': '173', 'author': 'H Quan', 'year': '2011', 'unstructured': 'Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, ' 'Sundararajan V. Updating and validating the Charlson comorbidity index ' 'and score for risk adjustment in hospital discharge abstracts using data ' 'from 6 countries. Am J Epidemiol. 2011;173:676–82.', 'journal-title': 'Am J Epidemiol'}, { 'key': '2464_CR26', 'doi-asserted-by': 'publisher', 'first-page': '3295', 'DOI': '10.1016/j.jacc.2019.04.052', 'volume': '73', 'author': 'SR Lee', 'year': '2019', 'unstructured': 'Lee SR, Lee HJ, Choi EK, Han KD, Jung JH, Cha MJ, Oh S, Lip GYH. Direct ' 'oral anticoagulants in patients with Atrial Fibrillation and Liver ' 'Disease. J Am Coll Cardiol. 2019;73:3295–308.', 'journal-title': 'J Am Coll Cardiol'}, { 'key': '2464_CR27', 'doi-asserted-by': 'publisher', 'first-page': 'e3085', 'DOI': '10.1093/cid/ciaa1624', 'volume': '73', 'author': 'VS Fan', 'year': '2021', 'unstructured': 'Fan VS, Dominitz JA, Eastment MC, Locke ER, Green P, Berry K, O’Hare AM, ' 'Shah JA, Crothers K, Ioannou GN. Risk factors for testing positive for ' 'severe Acute Respiratory Syndrome Coronavirus 2 in a National United ' 'States Healthcare System. Clin Infect Dis. 2021;73:e3085–94.', 'journal-title': 'Clin Infect Dis'}, { 'key': '2464_CR28', 'doi-asserted-by': 'publisher', 'first-page': '394', 'DOI': '10.1002/hep.30145', 'volume': '69', 'author': 'KD Lindor', 'year': '2019', 'unstructured': 'Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary ' 'cholangitis: 2018 Practice Guidance from the American Association for ' 'the study of Liver diseases. Hepatology. 2019;69:394–419.', 'journal-title': 'Hepatology'}, { 'key': '2464_CR29', 'doi-asserted-by': 'publisher', 'first-page': '425', 'DOI': '10.3350/cmh.2022.0186', 'volume': '28', 'author': 'HA Lee', 'year': '2022', 'unstructured': 'Lee HA, Chang Y, Sung PS, Yoon EL, Lee HW, Yoo J-J, Lee Y-S, An J, Song ' 'DS, Cho YY, et al. Therapeutic mechanisms and beneficial effects of ' 'non-antidiabetic drugs in chronic liver diseases. Clin Mol Hepatol. ' '2022;28:425–72.', 'journal-title': 'Clin Mol Hepatol'}, { 'key': '2464_CR30', 'doi-asserted-by': 'publisher', 'first-page': '620', 'DOI': '10.5009/gnl220420', 'volume': '17', 'author': 'J-I Chang', 'year': '2023', 'unstructured': 'Chang J-I, Kim JH, Sinn DH, Cho J-Y, Kim KM, Oh JH, Park Y, Sohn W, Goh ' 'MJ, Kang W, et al. Clinical outcomes and validation of Ursodeoxycholic ' 'Acid Response scores in patients with Korean primary biliary ' 'cholangitis: a Multicenter Cohort Study. Gut Liver. 2023;17:620–8.', 'journal-title': 'Gut Liver'}, { 'issue': 'Suppl 1', 'key': '2464_CR31', 'doi-asserted-by': 'publisher', 'first-page': 'S3', 'DOI': '10.1016/S2210-7401(12)70015-3', 'volume': '36', 'author': 'R Poupon', 'year': '2012', 'unstructured': 'Poupon R. Ursodeoxycholic acid and bile-acid mimetics as therapeutic ' 'agents for cholestatic liver diseases: an overview of their mechanisms ' 'of action. Clin Res Hepatol Gastroenterol. 2012;36(Suppl 1):S3–12.', 'journal-title': 'Clin Res Hepatol Gastroenterol'}, { 'key': '2464_CR32', 'doi-asserted-by': 'publisher', 'first-page': '105', 'DOI': '10.5483/BMBRep.2016.49.2.173', 'volume': '49', 'author': 'AR Oh', 'year': '2016', 'unstructured': 'Oh AR, Bae JS, Lee J, Shin E, Oh BC, Park SC, Cha JY. Ursodeoxycholic ' 'acid decreases age-related adiposity and inflammation in mice. BMB Rep. ' '2016;49:105–10.', 'journal-title': 'BMB Rep'}, { 'key': '2464_CR33', 'doi-asserted-by': 'publisher', 'first-page': 'G427', 'DOI': '10.1152/ajpgi.00205.2012', 'volume': '305', 'author': 'T Takigawa', 'year': '2013', 'unstructured': 'Takigawa T, Miyazaki H, Kinoshita M, Kawarabayashi N, Nishiyama K, ' 'Hatsuse K, Ono S, Saitoh D, Seki S, Yamamoto J. Glucocorticoid ' 'receptor-dependent immunomodulatory effect of ursodeoxycholic acid on ' 'liver lymphocytes in mice. Am J Physiol Gastrointest Liver Physiol. ' '2013;305:G427–438.', 'journal-title': 'Am J Physiol Gastrointest Liver Physiol'}, { 'key': '2464_CR34', 'doi-asserted-by': 'publisher', 'first-page': 'G735', 'DOI': '10.1152/ajpgi.90321.2008', 'volume': '295', 'author': 'K Okada', 'year': '2008', 'unstructured': 'Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, ' 'Goto N, Takeda K, Utsunomiya H, et al. Ursodeoxycholic acid stimulates ' 'Nrf2-mediated hepatocellular transport, detoxification, and ' 'antioxidative stress systems in mice. Am J Physiol Gastrointest Liver ' 'Physiol. 2008;295:G735–747.', 'journal-title': 'Am J Physiol Gastrointest Liver Physiol'}, { 'key': '2464_CR35', 'doi-asserted-by': 'publisher', 'first-page': '134', 'DOI': '10.1016/S1665-2681(19)31792-2', 'volume': '8', 'author': 'GA El-Sherbiny', 'year': '2009', 'unstructured': 'El-Sherbiny GA, Taye A, Abdel-Raheem IT. Role of ursodeoxycholic acid in ' 'prevention of hepatotoxicity caused by Amoxicillin-clavulanic acid in ' 'rats. Ann Hepatol. 2009;8:134–40.', 'journal-title': 'Ann Hepatol'}, { 'key': '2464_CR36', 'doi-asserted-by': 'publisher', 'first-page': '523', 'DOI': '10.1111/liv.13562', 'volume': '38', 'author': 'M Mueller', 'year': '2018', 'unstructured': 'Mueller M, Castro RE, Thorell A, Marschall HU, Auer N, Herac M, ' 'Rodrigues CMP, Trauner M. Ursodeoxycholic acid: effects on hepatic ' 'unfolded protein response, apoptosis and oxidative stress in morbidly ' 'obese patients. Liver Int. 2018;38:523–31.', 'journal-title': 'Liver Int'}, { 'key': '2464_CR37', 'doi-asserted-by': 'publisher', 'first-page': '905', 'DOI': '10.1007/s10096-020-04138-6', 'volume': '40', 'author': 'S Beyerstedt', 'year': '2021', 'unstructured': 'Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting ' 'enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 ' 'infection. Eur J Clin Microbiol Infect Dis. 2021;40:905–19.', 'journal-title': 'Eur J Clin Microbiol Infect Dis'}, { 'key': '2464_CR38', 'doi-asserted-by': 'crossref', 'unstructured': 'Fiorucci S, Urbani G, Biagioli M, Sepe V, Distrutti E, Zampella A. Bile ' 'acids and bile acid activated receptors in the treatment of Covid-19. ' 'Biochem Pharmacol 2023:115983.', 'DOI': '10.1016/j.bcp.2023.115983'}, { 'key': '2464_CR39', 'doi-asserted-by': 'publisher', 'first-page': '572885', 'DOI': '10.3389/fchem.2020.572885', 'volume': '8', 'author': 'A Carino', 'year': '2020', 'unstructured': 'Carino A, Moraca F, Fiorillo B, Marchianò S, Sepe V, Biagioli M, ' 'Finamore C, Bozza S, Francisci D, Distrutti E, et al. Hijacking ' 'SARS-CoV-2/ACE2 receptor Interaction by Natural and semi-synthetic ' 'Steroidal agents acting on functional pockets on the receptor binding ' 'domain. Front Chem. 2020;8:572885.', 'journal-title': 'Front Chem'}, { 'key': '2464_CR40', 'doi-asserted-by': 'publisher', 'first-page': '196', 'DOI': '10.1021/acs.jcim.1c01126', 'volume': '62', 'author': 'B Fiorillo', 'year': '2022', 'unstructured': 'Fiorillo B, Marchianò S, Moraca F, Sepe V, Carino A, Rapacciuolo P, ' 'Biagioli M, Limongelli V, Zampella A, Catalanotti B, Fiorucci S. ' 'Discovery of bile acid derivatives as potent ACE2 activators by virtual ' 'screening and essential dynamics. J Chem Inf Model. 2022;62:196–209.', 'journal-title': 'J Chem Inf Model'}, { 'key': '2464_CR41', 'doi-asserted-by': 'publisher', 'first-page': 'e0180673', 'DOI': '10.1371/journal.pone.0180673', 'volume': '12', 'author': 'WK Ko', 'year': '2017', 'unstructured': 'Ko WK, Lee SH, Kim SJ, Jo MJ, Kumar H, Han IB, Sohn S. Anti-inflammatory ' 'effects of ursodeoxycholic acid by lipopolysaccharide-stimulated ' 'inflammatory responses in RAW 264.7 macrophages. PLoS ONE. ' '2017;12:e0180673.', 'journal-title': 'PLoS ONE'}, { 'key': '2464_CR42', 'doi-asserted-by': 'publisher', 'first-page': '109897', 'DOI': '10.1016/j.mehy.2020.109897', 'volume': '143', 'author': 'S Abdulrab', 'year': '2020', 'unstructured': 'Abdulrab S, Al-Maweri S, Halboub E. Ursodeoxycholic acid as a candidate ' 'therapeutic to alleviate and/or prevent COVID-19-associated cytokine ' 'storm. Med Hypotheses. 2020;143:109897.', 'journal-title': 'Med Hypotheses'}, { 'key': '2464_CR43', 'doi-asserted-by': 'publisher', 'first-page': '1019', 'DOI': '10.1053/j.gastro.2023.01.014', 'volume': '164', 'author': 'K Prayitno', 'year': '2023', 'unstructured': 'Prayitno K, Bhat M. Repurposing UDCA, an FXR inhibitor, to prevent ' 'SARS-Cov-2 infection. Gastroenterology. 2023;164:1019–20.', 'journal-title': 'Gastroenterology'}, { 'key': '2464_CR44', 'doi-asserted-by': 'publisher', 'first-page': '100664', 'DOI': '10.1016/j.lanepe.2023.100664', 'volume': '30', 'author': 'S Contreras', 'year': '2023', 'unstructured': 'Contreras S, Iftekhar EN, Priesemann V. From emergency response to ' 'long-term management: the many faces of the endemic state of COVID-19. ' 'Lancet Reg Health Eur. 2023;30:100664.', 'journal-title': 'Lancet Reg Health Eur'}, { 'key': '2464_CR45', 'doi-asserted-by': 'publisher', 'first-page': '588', 'DOI': '10.1016/S2213-2600(23)00217-5', 'volume': '11', 'author': 'T Burki', 'year': '2023', 'unstructured': 'Burki T. WHO ends the COVID-19 public health emergency. Lancet Respir ' 'Med. 2023;11:588.', 'journal-title': 'Lancet Respir Med'}, { 'key': '2464_CR46', 'doi-asserted-by': 'publisher', 'first-page': '2851', 'DOI': '10.1097/JS9.0000000000000513', 'volume': '109', 'author': 'R Sarker', 'year': '2023', 'unstructured': 'Sarker R, Roknuzzaman ASM, Hossain MJ, Bhuiyan MA, Islam MR. The WHO ' 'declares COVID-19 is no longer a public health emergency of ' 'international concern: benefits, challenges, and necessary precautions ' 'to come back to normal life. Int J Surg. 2023;109:2851–2.', 'journal-title': 'Int J Surg'}, { 'key': '2464_CR47', 'doi-asserted-by': 'publisher', 'first-page': 'e2313', 'DOI': '10.1002/rmv.2313', 'volume': '32', 'author': 'I Hadj Hassine', 'year': '2022', 'unstructured': 'Hadj Hassine I. Covid-19 vaccines and variants of concern: a review. Rev ' 'Med Virol. 2022;32:e2313.', 'journal-title': 'Rev Med Virol'}, { 'key': '2464_CR48', 'doi-asserted-by': 'publisher', 'first-page': '1796', 'DOI': '10.1002/jmv.27574', 'volume': '94', 'author': 'M Sohan', 'year': '2022', 'unstructured': 'Sohan M, Hossain MJ, Islam MR. The SARS-CoV-2 Omicron (B.1.1.529) ' 'variant and effectiveness of existing vaccines: what we know so far. J ' 'Med Virol. 2022;94:1796–8.', 'journal-title': 'J Med Virol'}, { 'key': '2464_CR49', 'doi-asserted-by': 'publisher', 'first-page': '1011', 'DOI': '10.1056/NEJMra2206573', 'volume': '387', 'author': 'DH Barouch', 'year': '2022', 'unstructured': 'Barouch DH. Covid-19 vaccines - immunity, variants, boosters. N Engl J ' 'Med. 2022;387:1011–20.', 'journal-title': 'N Engl J Med'}, { 'key': '2464_CR50', 'doi-asserted-by': 'publisher', 'first-page': '1981', 'DOI': '10.1056/NEJMsa0806477', 'volume': '360', 'author': 'SB Omer', 'year': '2009', 'unstructured': 'Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, ' 'mandatory immunization, and the risks of vaccine-preventable diseases. N ' 'Engl J Med. 2009;360:1981–8.', 'journal-title': 'N Engl J Med'}, { 'key': '2464_CR51', 'doi-asserted-by': 'publisher', 'first-page': 'e0265496', 'DOI': '10.1371/journal.pone.0265496', 'volume': '17', 'author': 'DN Roy', 'year': '2022', 'unstructured': 'Roy DN, Biswas M, Islam E, Azam MS. Potential factors influencing ' 'COVID-19 vaccine acceptance and hesitancy: a systematic review. PLoS ' 'ONE. 2022;17:e0265496.', 'journal-title': 'PLoS ONE'}, { 'key': '2464_CR52', 'doi-asserted-by': 'publisher', 'first-page': '29', 'DOI': '10.1186/s13223-018-0250-0', 'volume': '14', 'author': 'HJ Park', 'year': '2018', 'unstructured': 'Park HJ, Byun MK, Kim HJ, Ahn CM, Rhee CK, Kim K, Kim BY, Bae HW, Yoo ' 'KH. Regular follow-up visits reduce the risk for asthma exacerbation ' 'requiring admission in Korean adults with asthma. Allergy Asthma Clin ' 'Immunol. 2018;14:29.', 'journal-title': 'Allergy Asthma Clin Immunol'}, { 'key': '2464_CR53', 'doi-asserted-by': 'publisher', 'first-page': '6049', 'DOI': '10.1038/s41598-020-63064-x', 'volume': '10', 'author': 'HJ Park', 'year': '2020', 'unstructured': 'Park HJ, Byun MK, Kim T, Rhee CK, Kim K, Kim BY, Ahn SI, Jo YU, Yoo KH. ' 'Frequent outpatient visits prevent exacerbation of Chronic Obstructive ' 'Pulmonary Disease. Sci Rep. 2020;10:6049.', 'journal-title': 'Sci Rep'}, { 'key': '2464_CR54', 'doi-asserted-by': 'publisher', 'first-page': '717', 'DOI': '10.1093/ije/dyaa033', 'volume': '49', 'author': 'NC Peeri', 'year': '2020', 'unstructured': 'Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, ' 'Aghamohammadi N, Zhang W, Haque U. The SARS, MERS and novel coronavirus ' '(COVID-19) epidemics, the newest and biggest global health threats: what ' 'lessons have we learned? Int J Epidemiol. 2020;49:717–26.', 'journal-title': 'Int J Epidemiol'}], 'container-title': 'Virology Journal', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1186/s12985-024-02464-1.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1186/s12985-024-02464-1/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1186/s12985-024-02464-1.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 8, 27]], 'date-time': '2024-08-27T19:02:23Z', 'timestamp': 1724785343000}, 'score': 1, 'resource': {'primary': {'URL': 'https://virologyj.biomedcentral.com/articles/10.1186/s12985-024-02464-1'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 8, 27]]}, 'references-count': 54, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 12]]}}, 'alternative-id': ['2464'], 'URL': 'http://dx.doi.org/10.1186/s12985-024-02464-1', 'relation': {}, 'ISSN': ['1743-422X'], 'subject': [], 'container-title-short': 'Virol J', 'published': {'date-parts': [[2024, 8, 27]]}, 'assertion': [ { 'value': '22 May 2024', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '7 August 2024', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '27 August 2024', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The Dong-A University College of Medicine Institutional Review Board exempted ' 'this retrospective study from review due to its design (utilizing ' 'de-identified, publicly available clinical data for analysis) ' '(DAUHIRB-EXP-23-026).', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics approval and consent to participate'}}, { 'value': 'Not applicable.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent for publication'}}, { 'value': 'This study used the database of the KDCA and the NHIS for policy and academic ' 'research. The research number of this study is KDCA-NHIS-2023-1-567. The KDCA ' 'is the Korea Disease Control and Prevention Agency, Republic of Korea. The NHIS ' 'is the National Health Insurance Service, Republic of Korea.', 'order': 4, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Additional information'}}, { 'value': 'The authors declare no competing interests.', 'order': 5, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}], 'article-number': '202'}